Peptide Synthesis Market 2028 By Product, Therapeutic Area, End User, and Geography | The Insight Partners

    Peptide Synthesis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Reagents, Synthesizers, and Chromatography); Therapeutic Area (Cardiovascular Disorder, Cancer, Respiratory Disorder, Metabolic Disorder, Dermatology, and Others); End User (Pharmaceutical and Biotechnological Companies, Contract Research Organizations (CRO's), Academic and Research Institutes, and Others), and Geography

    Report Code: TIPBT00002596 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

    MARKET OVERVIEW

    Peptides are drug compounds that are both active and very unique. Since peptides have a more comprehensive range of biological functions, they are used in a wide range of therapeutic areas. Furthermore, because of their vast chemical space, high specificity, physical activity, relative ease of synthesis, ready availability, and low toxicity, they are increasingly considered potential active pharmaceutical ingredients in drug production. These are used to treat various illnesses, including cancer, cardiovascular disease, respiratory problems, and others.

    MARKET SCOPE

    The "Global Peptide Synthesis Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the peptide synthesis market with detailed market segmentation by product, therapeutic area, end user, and geography. The report provides key statistics on the market status of the leading peptide synthesis market players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION

    • Based on product, the global peptide synthesis market is segmented into reagents, synthesizers, and chromatography.
    • Based on therapeutic area, the market is bifurcated into cardiovascular disorder, cancer, respiratory disorder, metabolic disorder, dermatology, and others.
    • Based on end user, the market is bifurcated into pharmaceutical and biotechnological companies, contract research organizations (CRO's), academic and research institutes, and others.

    MARKET DYNAMICS

    Drivers

    • Increase in research activities and availability of funding for R&D
    • Rising demand for custom made peptides
    • Strong peptide therapeutics pipeline

    Restraints

    • Lack of supplier-customer network
    • Lack of regulations for therapeutic peptide

    REGIONAL FRAMEWORK

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The peptide synthesis market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

    The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the peptide synthesis market in these regions.

    IMPACT OF COVID-19 ON PEPTIDE SYNTHESIS MARKET

    COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

    MARKET PLAYERS

    The report covers key developments in the peptide synthesis market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from peptide synthesis market are anticipated to lucrative growth opportunities in the future with the rising demand for peptide synthesis in the global market.

    The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the peptide synthesis market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    • Merck KGaA
    • Aapptec
    • CEM Corporation
    • Pfizer Inc.
    • Sanofi
    • GenScript
    • Biotage
    • Eli Lilly and Company
    • Teva Pharmaceutical
    • AstraZeneca Plc

    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Peptide Synthesis Market - By Product
    1.3.2 Peptide Synthesis Market - By Therapeutic Area
    1.3.3 Peptide Synthesis Market - By End User
    1.3.4 Peptide Synthesis Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. PEPTIDE SYNTHESIS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. PEPTIDE SYNTHESIS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. PEPTIDE SYNTHESIS MARKET - GLOBAL MARKET ANALYSIS
    6.1. PEPTIDE SYNTHESIS - GLOBAL MARKET OVERVIEW
    6.2. PEPTIDE SYNTHESIS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING
    7. PEPTIDE SYNTHESIS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
    7.1. OVERVIEW
    7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
    7.3. REAGENTS
    7.3.1. Overview
    7.3.2. Reagents Market Forecast and Analysis
    7.4. SYNTHESIZERS
    7.4.1. Overview
    7.4.2. Synthesizers Market Forecast and Analysis
    7.5. CHROMATOGRAPHY
    7.5.1. Overview
    7.5.2. Chromatography Market Forecast and Analysis
    8. PEPTIDE SYNTHESIS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTIC AREA
    8.1. OVERVIEW
    8.2. THERAPEUTIC AREA MARKET FORECASTS AND ANALYSIS
    8.3. CARDIOVASCULAR DISORDER
    8.3.1. Overview
    8.3.2. Cardiovascular Disorder Market Forecast and Analysis
    8.4. CANCER
    8.4.1. Overview
    8.4.2. Cancer Market Forecast and Analysis
    8.5. RESPIRATORY DISORDER
    8.5.1. Overview
    8.5.2. Respiratory Disorder Market Forecast and Analysis
    8.6. METABOLIC DISORDER
    8.6.1. Overview
    8.6.2. Metabolic Disorder Market Forecast and Analysis
    8.7. DERMATOLOGY
    8.7.1. Overview
    8.7.2. Dermatology Market Forecast and Analysis
    8.8. OTHERS
    8.8.1. Overview
    8.8.2. Others Market Forecast and Analysis
    9. PEPTIDE SYNTHESIS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
    9.1. OVERVIEW
    9.2. END USER MARKET FORECASTS AND ANALYSIS
    9.3. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
    9.3.1. Overview
    9.3.2. Pharmaceutical and Biotechnological Companies Market Forecast and Analysis
    9.4. CONTRACT RESEARCH ORGANIZATIONS (CRO'S)
    9.4.1. Overview
    9.4.2. Contract Research Organizations (CRO's) Market Forecast and Analysis
    9.5. ACADEMIC AND RESEARCH INSTITUTES
    9.5.1. Overview
    9.5.2. Academic and Research Institutes Market Forecast and Analysis
    9.6. OTHERS
    9.6.1. Overview
    9.6.2. Others Market Forecast and Analysis
    10. PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Peptide Synthesis Market Overview
    10.1.2 North America Peptide Synthesis Market Forecasts and Analysis
    10.1.3 North America Peptide Synthesis Market Forecasts and Analysis - By Product
    10.1.4 North America Peptide Synthesis Market Forecasts and Analysis - By Therapeutic Area
    10.1.5 North America Peptide Synthesis Market Forecasts and Analysis - By End User
    10.1.6 North America Peptide Synthesis Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Peptide Synthesis Market
    10.1.6.1.1 United States Peptide Synthesis Market by Product
    10.1.6.1.2 United States Peptide Synthesis Market by Therapeutic Area
    10.1.6.1.3 United States Peptide Synthesis Market by End User
    10.1.6.2 Canada Peptide Synthesis Market
    10.1.6.2.1 Canada Peptide Synthesis Market by Product
    10.1.6.2.2 Canada Peptide Synthesis Market by Therapeutic Area
    10.1.6.2.3 Canada Peptide Synthesis Market by End User
    10.1.6.3 Mexico Peptide Synthesis Market
    10.1.6.3.1 Mexico Peptide Synthesis Market by Product
    10.1.6.3.2 Mexico Peptide Synthesis Market by Therapeutic Area
    10.1.6.3.3 Mexico Peptide Synthesis Market by End User
    10.2. EUROPE
    10.2.1 Europe Peptide Synthesis Market Overview
    10.2.2 Europe Peptide Synthesis Market Forecasts and Analysis
    10.2.3 Europe Peptide Synthesis Market Forecasts and Analysis - By Product
    10.2.4 Europe Peptide Synthesis Market Forecasts and Analysis - By Therapeutic Area
    10.2.5 Europe Peptide Synthesis Market Forecasts and Analysis - By End User
    10.2.6 Europe Peptide Synthesis Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Peptide Synthesis Market
    10.2.6.1.1 Germany Peptide Synthesis Market by Product
    10.2.6.1.2 Germany Peptide Synthesis Market by Therapeutic Area
    10.2.6.1.3 Germany Peptide Synthesis Market by End User
    10.2.6.2 France Peptide Synthesis Market
    10.2.6.2.1 France Peptide Synthesis Market by Product
    10.2.6.2.2 France Peptide Synthesis Market by Therapeutic Area
    10.2.6.2.3 France Peptide Synthesis Market by End User
    10.2.6.3 Italy Peptide Synthesis Market
    10.2.6.3.1 Italy Peptide Synthesis Market by Product
    10.2.6.3.2 Italy Peptide Synthesis Market by Therapeutic Area
    10.2.6.3.3 Italy Peptide Synthesis Market by End User
    10.2.6.4 Spain Peptide Synthesis Market
    10.2.6.4.1 Spain Peptide Synthesis Market by Product
    10.2.6.4.2 Spain Peptide Synthesis Market by Therapeutic Area
    10.2.6.4.3 Spain Peptide Synthesis Market by End User
    10.2.6.5 United Kingdom Peptide Synthesis Market
    10.2.6.5.1 United Kingdom Peptide Synthesis Market by Product
    10.2.6.5.2 United Kingdom Peptide Synthesis Market by Therapeutic Area
    10.2.6.5.3 United Kingdom Peptide Synthesis Market by End User
    10.2.6.6 Rest of Europe Peptide Synthesis Market
    10.2.6.6.1 Rest of Europe Peptide Synthesis Market by Product
    10.2.6.6.2 Rest of Europe Peptide Synthesis Market by Therapeutic Area
    10.2.6.6.3 Rest of Europe Peptide Synthesis Market by End User
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Peptide Synthesis Market Overview
    10.3.2 Asia-Pacific Peptide Synthesis Market Forecasts and Analysis
    10.3.3 Asia-Pacific Peptide Synthesis Market Forecasts and Analysis - By Product
    10.3.4 Asia-Pacific Peptide Synthesis Market Forecasts and Analysis - By Therapeutic Area
    10.3.5 Asia-Pacific Peptide Synthesis Market Forecasts and Analysis - By End User
    10.3.6 Asia-Pacific Peptide Synthesis Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Peptide Synthesis Market
    10.3.6.1.1 Australia Peptide Synthesis Market by Product
    10.3.6.1.2 Australia Peptide Synthesis Market by Therapeutic Area
    10.3.6.1.3 Australia Peptide Synthesis Market by End User
    10.3.6.2 China Peptide Synthesis Market
    10.3.6.2.1 China Peptide Synthesis Market by Product
    10.3.6.2.2 China Peptide Synthesis Market by Therapeutic Area
    10.3.6.2.3 China Peptide Synthesis Market by End User
    10.3.6.3 India Peptide Synthesis Market
    10.3.6.3.1 India Peptide Synthesis Market by Product
    10.3.6.3.2 India Peptide Synthesis Market by Therapeutic Area
    10.3.6.3.3 India Peptide Synthesis Market by End User
    10.3.6.4 Japan Peptide Synthesis Market
    10.3.6.4.1 Japan Peptide Synthesis Market by Product
    10.3.6.4.2 Japan Peptide Synthesis Market by Therapeutic Area
    10.3.6.4.3 Japan Peptide Synthesis Market by End User
    10.3.6.5 South Korea Peptide Synthesis Market
    10.3.6.5.1 South Korea Peptide Synthesis Market by Product
    10.3.6.5.2 South Korea Peptide Synthesis Market by Therapeutic Area
    10.3.6.5.3 South Korea Peptide Synthesis Market by End User
    10.3.6.6 Rest of Asia-Pacific Peptide Synthesis Market
    10.3.6.6.1 Rest of Asia-Pacific Peptide Synthesis Market by Product
    10.3.6.6.2 Rest of Asia-Pacific Peptide Synthesis Market by Therapeutic Area
    10.3.6.6.3 Rest of Asia-Pacific Peptide Synthesis Market by End User
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Peptide Synthesis Market Overview
    10.4.2 Middle East and Africa Peptide Synthesis Market Forecasts and Analysis
    10.4.3 Middle East and Africa Peptide Synthesis Market Forecasts and Analysis - By Product
    10.4.4 Middle East and Africa Peptide Synthesis Market Forecasts and Analysis - By Therapeutic Area
    10.4.5 Middle East and Africa Peptide Synthesis Market Forecasts and Analysis - By End User
    10.4.6 Middle East and Africa Peptide Synthesis Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Peptide Synthesis Market
    10.4.6.1.1 South Africa Peptide Synthesis Market by Product
    10.4.6.1.2 South Africa Peptide Synthesis Market by Therapeutic Area
    10.4.6.1.3 South Africa Peptide Synthesis Market by End User
    10.4.6.2 Saudi Arabia Peptide Synthesis Market
    10.4.6.2.1 Saudi Arabia Peptide Synthesis Market by Product
    10.4.6.2.2 Saudi Arabia Peptide Synthesis Market by Therapeutic Area
    10.4.6.2.3 Saudi Arabia Peptide Synthesis Market by End User
    10.4.6.3 U.A.E Peptide Synthesis Market
    10.4.6.3.1 U.A.E Peptide Synthesis Market by Product
    10.4.6.3.2 U.A.E Peptide Synthesis Market by Therapeutic Area
    10.4.6.3.3 U.A.E Peptide Synthesis Market by End User
    10.4.6.4 Rest of Middle East and Africa Peptide Synthesis Market
    10.4.6.4.1 Rest of Middle East and Africa Peptide Synthesis Market by Product
    10.4.6.4.2 Rest of Middle East and Africa Peptide Synthesis Market by Therapeutic Area
    10.4.6.4.3 Rest of Middle East and Africa Peptide Synthesis Market by End User
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Peptide Synthesis Market Overview
    10.5.2 South and Central America Peptide Synthesis Market Forecasts and Analysis
    10.5.3 South and Central America Peptide Synthesis Market Forecasts and Analysis - By Product
    10.5.4 South and Central America Peptide Synthesis Market Forecasts and Analysis - By Therapeutic Area
    10.5.5 South and Central America Peptide Synthesis Market Forecasts and Analysis - By End User
    10.5.6 South and Central America Peptide Synthesis Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Peptide Synthesis Market
    10.5.6.1.1 Brazil Peptide Synthesis Market by Product
    10.5.6.1.2 Brazil Peptide Synthesis Market by Therapeutic Area
    10.5.6.1.3 Brazil Peptide Synthesis Market by End User
    10.5.6.2 Argentina Peptide Synthesis Market
    10.5.6.2.1 Argentina Peptide Synthesis Market by Product
    10.5.6.2.2 Argentina Peptide Synthesis Market by Therapeutic Area
    10.5.6.2.3 Argentina Peptide Synthesis Market by End User
    10.5.6.3 Rest of South and Central America Peptide Synthesis Market
    10.5.6.3.1 Rest of South and Central America Peptide Synthesis Market by Product
    10.5.6.3.2 Rest of South and Central America Peptide Synthesis Market by Therapeutic Area
    10.5.6.3.3 Rest of South and Central America Peptide Synthesis Market by End User
    11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PEPTIDE SYNTHESIS MARKET
    11.1 North America
    11.2 Europe
    11.3 Asia-Pacific
    11.4 Middle East and Africa
    11.5 South and Central America
    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    13. PEPTIDE SYNTHESIS MARKET, KEY COMPANY PROFILES
    13.1. MERCK KGAA
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. AAPPTEC
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. CEM CORPORATION
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. PFIZER INC.
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. SANOFI
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. GENSCRIPT
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. BIOTAGE
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. ELI LILLY AND COMPANY
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. TEVA PHARMACEUTICAL
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. ASTRAZENECA PLC.
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments
    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS

    The List of Companies

    1. Merck KGaA
    2. Aapptec
    3. CEM Corporation
    4. Pfizer Inc.
    5. Sanofi
    6. GenScript
    7. Biotage
    8. Eli Lilly and Company
    9. Teva Pharmaceutical
    10. AstraZeneca Plc
    11. Lonza
    12. MP Biomedicals
    13. PuroSynth
    14. Polypeptide Group
    15. Syngene
    16. Novo Nordisk A/S
    17. Bachem Holdings
    18. New England Peptide, Inc.
    19. Gyros Protein Technologies
    20. AnaSpec

    TIPBT00002596
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount